Apex Global Meetings is delighted to announce and cordially invites all the participants across the globe to attend “Global Summit on Cardiology and cardiovascular Diseases” GSCCD2024 which will be taking place during December 05-07, 2024 at Rome, Italy.
aims to gather the renowned scientists, young and brilliant researchers,
academicians, cardiologists, healthcare professionals, business delegates, and
exceptional student communities across the globe under one roof and organize a
healthy discussion so that the researchers and authors can present their work
at the conference. GSCCD2024 objective is to provide a comprehensive global
forum for experts and participants from academia to exchange ideas and present
results of on-going research in the most state-of-the-art areas of Cardiology
and Cardiovascular Diseases and allied topics. It will be hosting a forum of
plenary, keynote, Invited lectures and oral/ poster presentations.
accept this gathering will be an exceptionally remunerating instructive and
collaborative occasion for the attendees.
look forward to your valuable presence at GSCCD2024 in Rome, Italy.
Olive S | Program Coordinator
Apex Global Meetings
Contact no: 8977610040
Cardiac Problems in Pregnancy
Cardio-metabolic Health- Diabetes & Obesity
Cardiomyopathy and Heart Failure
Cardiovascular Surgery & Healthcare
Clinical Case Reports on Cardiology
Congenital Heart Diseases
Critical Cardiac Care
Device Therapies for Heart Failure
Diabetic Cardiovascular Disease
Obesity and Heart
Stem Cell Regeneration on Cardiology
Women and Cardiac Arrhythmia
The increasing prevalence of cardiovascular diseases and
technological advancements have significantly improved the design and
functionality of the interventional cardiology market and have carved the way
for market growth. In addition, the rising healthcare expenditure and the
increasing geriatric population contribute to the market growth.
Data Bridge Market Research analyzes that the global
interventional cardiology market, which was USD 14.61 billion in 2022, would
rocket up to USD 23.61 billion by 2030, and is expected to undergo a CAGR of
7.1% during the forecast period. This indicates that the conventional device
segment dominates the device type segment of the market owing to the
advancements in technology that have led to the development of advancements in
interventional cardiology for various use.
In addition to the insights on market scenarios such as market
value, growth rate, segmentation, geographical coverage, and major players, the
market reports curated by the Data Bridge Market Research also include depth
expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and